High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets

被引:41
作者
Ragab, Marwa A. A. [1 ]
El-Kimary, Eman I. [1 ]
机构
[1] Univ Alexandria, Dept Pharmaceut Analyt Chem, Fac Pharm, Alexandria 21521, Egypt
关键词
Naproxen; Esomeprazole; Chiral impurities; Chiral HPLC-DAD; OMEPRAZOLE; DRUGS; FORMULATIONS; VALIDATION; RESOLUTION;
D O I
10.1016/j.chroma.2017.03.059
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A stereoselective high performance liquid chromatographic method with diode array detection (HPLC-DAD) was introduced for S-naproxen and esomeprazole determination in tablets. The separation was achieved on a Kromasil Cellucoat chiral column using a mobile phase consisting of hexane: isopropanol: trifluoroacetic acid (TFA) (90:9.9:0.1 v/v/v). The proposed system was found to be suitable for the enantioseparation of naproxen and omeprazole biologically active isomers. After optimization of the chromatographic conditions, resolution values of 3.84 and 2.17 could be obtained for naproxen and omeprazole isomers, respectively. The method was fully validated for the determination of S-isomers of each drug in their dosage form. Also, the enentiomeric purity was determined in commercial tablet containing S-naproxen and esomeprazole. The enantiomeric purity was calculated for each drug and the chiral impurities (R-isomers) could be determined at 1% level. The method was validated and good results with respect to linearity, precision, accuracy, selectivity and robustness were obtained. The limits of detection (LOD) and quantification (LOQ) were 2.00, 6.50 and 0.10, 0.35 mu g mL(-1) for S-naproxen and esomeprazole, respectively. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:110 / 117
页数:8
相关论文
共 22 条
[1]  
Aboul-Enein H.Y., 2003, Chiral separations by liquid chromatography and related technologies, P1
[2]   Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole [J].
Andersson, T ;
Hassan-Alin, M ;
Hasselgren, G ;
Röhss, K ;
Weidolf, L .
CLINICAL PHARMACOKINETICS, 2001, 40 (06) :411-426
[3]  
[Anonymous], 1992, Chirality, V4, P338
[4]  
[Anonymous], 2005, Validation of analytical procedures: Text and methodology Q2 (R1)
[5]   Enantioselective analysis of omeprazole in pharmaceutical formulations by chiral high-performance liquid chromatography and capillary electrophoresis [J].
Bonato, PS ;
Paias, FO .
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2004, 15 (02) :318-323
[6]   Enantiomeric separation of naproxen by high performance liquid chromatography using CHIRALCEL OD as stationary phase [J].
Chen De-Miao ;
Qiang, Fu ;
Na, Li ;
Zhang Song-Xian ;
Zhang Qian-Qian .
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2007, 35 (01) :75-78
[7]  
Collins A.N., 1997, DEV COMMERCIAL MANUF
[8]   Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography [J].
del Nozal, MJ ;
Toribio, L ;
Bernal, JL ;
Alonso, C ;
Jiménez, JJ .
JOURNAL OF SEPARATION SCIENCE, 2004, 27 (12) :1023-1029
[9]   A Validated High-Performance Thin-Layer Chromatographic Method for the Assay of Two Binary Mixtures Containing Omeprazole or Its Isomer Esomeprazole in Pharmaceutical Dosage Forms [J].
El-Kimary, Eman I. ;
Ragab, Marwa A. A. .
JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2015, 28 (01) :74-82
[10]   Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma [J].
Gopinath, Shanmugam ;
Kumar, Ramadass Satiesh ;
Shankar, Madhira Bhawani ;
Danabal, Palanisamy .
BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (07) :894-899